30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ENDRA Life Sciences Inc (NDRA)

Track

Stock chart
Ticker: NDRA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
UBS Group AG
1 purchase — total 2,052 USD
Buy 27 Aug 2024
Value US$3,080,243.67 | Price 347.78 | Shares 17,270
Buy 18 May 2023
Value US$244,651.00 | Price 302.33 | Shares 30,960
Buy 2 May 2023
Value US$99,999.60 | Price 1.20 | Shares 83,333
Buy 9 Dec 2022
Value US$5,100.00 | Price 3.40 | Shares 1,500
Buy 23 Nov 2022
Value US$1,700.00 | Price 0.17 | Shares 10,000
Buy 22 Aug 2022
Value US$5,200.00 | Price 0.26 | Shares 20,000
Buy 22 Aug 2022
Value US$5,400.00 | Price 0.27 | Shares 20,000
Buy 26 May 2022
Value US$5,250.00 | Price 0.21 | Shares 25,000
Buy 18 May 2022
Value US$5,500.00 | Price 0.22 | Shares 25,000
Buy 17 May 2022
Value US$969.00 | Price 0.19 | Shares 5,100
Buy 16 May 2022
Value US$19,630.00 | Price 0.20 | Shares 100,000
Planned sale 7 Apr 2021
Value US$37,950.00 | Price 2.53 | Shares 15,000
Planned sale 29 Mar 2021
Value US$44,437.50 | Price 2.37 | Shares 18,750
Planned sale 13 Jan 2021
Value US$15,065.60 | Price 1.10 | Shares 13,696
Planned sale 12 Jan 2021
Value US$6,619.20 | Price 1.05 | Shares 6,304
Planned sale 8 Jan 2021
Value US$9,000.00 | Price 0.90 | Shares 10,000
Planned sale 8 Jan 2021
Value US$8,207.14 | Price 0.94 | Shares 8,731
Planned sale 6 Jan 2021
Value US$31,410.00 | Price 0.90 | Shares 34,900
Planned sale 6 Jan 2021
Value US$10,592.86 | Price 0.94 | Shares 11,269
Planned sale 5 Jan 2021
Value US$90.00 | Price 0.90 | Shares 100
Planned sale 17 Dec 2020
Value US$18,250.00 | Price 0.73 | Shares 25,000
Planned sale 4 Dec 2020
Value US$59,360.77 | Price 0.83 | Shares 71,519
Planned sale 13 Nov 2020
Value US$8,100.00 | Price 0.81 | Shares 10,000
Planned sale 1 Oct 2020
Value US$7,200.00 | Price 0.72 | Shares 10,000
Buy 8 Jun 2020
Value US$4,600.00 | Price 0.92 | Shares 5,000
Buy 29 May 2020
Value US$9,000.00 | Price 0.90 | Shares 10,000
Buy 28 May 2020
Value US$9,100.00 | Price 0.91 | Shares 10,000
Buy 28 May 2020
Value US$4,500.00 | Price 0.90 | Shares 5,000
Buy 27 May 2020
Value US$8,500.00 | Price 0.85 | Shares 10,000
Buy 26 May 2020
Value US$8,200.00 | Price 0.82 | Shares 10,000
Buy 22 May 2020
Value US$7,800.00 | Price 0.78 | Shares 10,000
Buy 21 May 2020
Value US$7,100.00 | Price 0.71 | Shares 10,000
Buy 27 Sep 2019
Value US$11,800.00 | Price 1.18 | Shares 10,000
Buy 23 Aug 2019
Value US$7,750.00 | Price 1.55 | Shares 5,000
Buy 22 Aug 2019
Value US$7,800.00 | Price 1.56 | Shares 5,000
Buy 10 Jun 2019
Value US$570.00 | Price 1.14 | Shares 500
Buy 7 Jun 2019
Value US$3,136.00 | Price 1.12 | Shares 2,800
Buy 6 Jun 2019
Value US$7,326.00 | Price 1.11 | Shares 6,600
Buy 5 Jun 2019
Value US$120.00 | Price 1.20 | Shares 100
Buy 16 May 2019
Value US$33,900.00 | Price 1.13 | Shares 30,000
Sale 24 Oct 2018
Value US$125,283.00 | Price 4.18 | Shares 30,000
Sale 23 Oct 2018
Value US$210,885.00 | Price 4.22 | Shares 50,000
Sale 22 Oct 2018
Value US$209,077.98 | Price 4.16 | Shares 50,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-29 2024-08-27 B Purchase
2.0
UBS Group AG
Large shareholder
17,270 -40.0%
347.78
US$3,080,244 		17,270 -40.0% 347.78 US$3,080,244
2023-05-22 2023-05-18 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
30,960 -24.7%
302.33
US$244,651 		30,960 -24.7% 302.33 US$244,651
2023-05-03 2023-05-02 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
16,695 +38.8%
108.11
US$1,937,782 		16,695 +38.8% 108.11 US$1,937,782
2022-12-13 2022-12-09 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
1,500 +8.5%
3.40
US$5,100 		1,500 +8.5% 3.40 US$5,100
2022-11-28 2022-11-23 B Purchase
1.4
Tokman Alexander Y
Non-Executive Director
10,000 +6.5%
0.17
US$1,700 		10,000 +6.5% 0.17 US$1,700
2022-08-24 2022-08-22 B Purchase
1.4
Tokman Alexander Y
Non-Executive Director
20,000 +15.1%
0.26
US$5,200 		20,000 +15.1% 0.26 US$5,200
2022-08-24 2022-08-22 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
20,000 +6.0%
0.27
US$5,400 		20,000 +6.0% 0.27 US$5,400
2022-05-31 2022-05-26 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
25,000 +8.1%
0.21
US$5,250 		25,000 +8.1% 0.21 US$5,250
2022-05-23 2022-05-18 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
25,000 +8.8%
0.22
US$5,500 		25,000 +8.8% 0.22 US$5,500
2022-05-19 2022-05-17 B Purchase
0.5
Michelon Francois Roger

Chief Executive Officer

Executive Director
5,100 +5.5%
0.19
US$969 		5,100 +5.5% 0.19 US$969
2022-05-17 2022-05-16 B Purchase
1.4
Tokman Alexander Y
Non-Executive Director
100,000 +304.3%
0.20
US$19,630 		100,000 +304.3% 0.20 US$19,630
2021-04-07 2021-04-07 PlS Planned sale
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
15,000 -5.5%
2.53
US$37,950 		15,000 -5.5% 2.53 US$37,950
2021-04-07 2021-03-29 PlS Planned sale
1.3
Thornton Michael Milos

Chief Technology Officer

Officer
18,750 -6.4%
2.37
US$44,438 		18,750 -6.4% 2.37 US$44,438
2021-01-14 2021-01-13 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
13,696 -89.7%
1.10
US$15,066 		13,696 -89.7% 1.10 US$15,066
2021-01-14 2021-01-12 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
6,304 -29.2%
1.05
US$6,619 		6,304 -29.2% 1.05 US$6,619
2021-01-08 2021-01-08 PlS Planned sale
1.4
Tokman Alexander Y
Non-Executive Director
10,000 -23.3%
0.90
US$9,000 		10,000 -23.3% 0.90 US$9,000
2021-01-08 2021-01-08 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
8,731 -28.8%
0.94
US$8,207 		8,731 -28.8% 0.94 US$8,207
2021-01-06 2021-01-06 PlS Planned sale
0.5
Wells David R.

Chief Financial Officer

Officer
34,900 -30.4%
0.90
US$31,410 		34,900 -30.4% 0.90 US$31,410
2021-01-06 2021-01-06 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
11,269 -27.1%
0.94
US$10,593 		11,269 -27.1% 0.94 US$10,593
2021-01-06 2021-01-05 PlS Planned sale
0.5
Wells David R.

Chief Financial Officer

Officer
100 -0.1%
0.90
US$90 		100 -0.1% 0.90 US$90
2020-12-21 2020-12-17 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
25,000 -37.5%
0.73
US$18,250 		25,000 -37.5% 0.73 US$18,250
2020-12-08 2020-12-04 PlS Planned sale
0.5
Michelon Francois Roger

Chief Executive Officer

Executive Director
71,519 -43.7%
0.83
US$59,361 		71,519 -43.7% 0.83 US$59,361
2020-11-16 2020-11-13 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
10,000 -13.1%
0.81
US$8,100 		10,000 -13.1% 0.81 US$8,100
2020-10-05 2020-10-01 PlS Planned sale
Maloberti Renaud Bertrand

Chief Commercial Officer

Officer
10,000 -11.6%
0.72
US$7,200 		10,000 -11.6% 0.72 US$7,200
2020-06-09 2020-06-08 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
5,000 +1.8%
0.92
US$4,600 		5,000 +1.8% 0.92 US$4,600
2020-06-01 2020-05-29 B Purchase
0.9
Basenese Lou
Non-Executive Director
10,000 +11.2%
0.90
US$9,000 		10,000 +11.2% 0.90 US$9,000
2020-05-29 2020-05-28 B Purchase
0.9
Basenese Lou
Non-Executive Director
10,000 +12.6%
0.91
US$9,100 		10,000 +12.6% 0.91 US$9,100
2020-05-29 2020-05-28 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
5,000 +1.8%
0.90
US$4,500 		5,000 +1.8% 0.90 US$4,500
2020-05-28 2020-05-27 B Purchase
0.9
Basenese Lou
Non-Executive Director
10,000 +14.5%
0.85
US$8,500 		10,000 +14.5% 0.85 US$8,500
2020-05-27 2020-05-26 B Purchase
0.9
Basenese Lou
Non-Executive Director
10,000 +16.9%
0.82
US$8,200 		10,000 +16.9% 0.82 US$8,200
2020-05-26 2020-05-22 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +4.1%
0.78
US$7,800 		10,000 +4.1% 0.78 US$7,800
2020-05-22 2020-05-21 B Purchase
0.9
Basenese Lou
Non-Executive Director
10,000 +20.4%
0.71
US$7,100 		10,000 +20.4% 0.71 US$7,100
2019-09-30 2019-09-27 B Purchase
0.5
Wells David R.

Chief Financial Officer
10,000 +100.0%
1.18
US$11,800 		10,000 +100.0% 1.18 US$11,800
2019-08-26 2019-08-23 B Purchase Wells David R.

Chief Financial Officer

Officer
5,000 +100.0%
1.55
US$7,750 		5,000 +100.0% 1.55 US$7,750
2019-08-26 2019-08-22 B Purchase Wells David R.

Chief Financial Officer

Officer
5,000 +inf%
1.56
US$7,800 		5,000 +inf% 1.56 US$7,800
2019-06-14 2019-06-10 B Purchase
0.9
Harsh Michael
500 +5.3%
1.14
US$570 		500 +5.3% 1.14 US$570
2019-06-10 2019-06-07 B Purchase
0.9
Harsh Michael
2,800 +41.8%
1.12
US$3,136 		2,800 +41.8% 1.12 US$3,136
2019-06-10 2019-06-06 B Purchase
0.9
Harsh Michael
6,600 +6600.0%
1.11
US$7,326 		6,600 +6600.0% 1.11 US$7,326
2019-06-10 2019-06-05 B Purchase
0.9
Harsh Michael
100 +inf%
1.20
US$120 		100 +inf% 1.20 US$120
2019-05-20 2019-05-16 B Purchase
1.3
Thornton Michael Milos

Chief Technology Officer
30,000 +33.4%
1.13
US$33,900 		30,000 +33.4% 1.13 US$33,900
2018-10-24 2018-10-24 S Sale Longboard Capital Advisors, LLC Large shareholder
30,000 -9.1%
4.18
US$125,283 		30,000 -9.1% 4.18 US$125,283
2018-10-24 2018-10-23 S Sale Longboard Capital Advisors, LLC Large shareholder
50,000 -13.2%
4.22
US$210,885 		50,000 -13.2% 4.22 US$210,885
2018-10-24 2018-10-22 S Sale Longboard Capital Advisors, LLC Large shareholder
50,200 -11.7%
4.16
US$209,078 		50,200 -11.7% 4.16 US$209,078
Explore more

More insider trading research around ENDRA Life Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America